A. Bowie et al., A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling, P NAS US, 97(18), 2000, pp. 10162-10167
Citations number
38
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Poxviruses employ many strategies to evade and neutralize the host immune r
esponse. In this study, we have identified two vaccinia virus ORFs, termed
A46R and A52R, that share amino acid sequence similarity with the Toll/IL-1
receptor (TIR) domain, a motif that defines the IL-1/Toll-like receptor (T
LR) superfamily of receptors, which have a key role in innate immunity and
inflammation. When expressed in mammalian cells, the protein products of bo
th ORFs were shown to interfere specifically with IL-1 signal transduction.
A46R partially inhibited IL-1-mediated activation of the transcription fac
tor NF kappa B, and A52R potently blocked both IL-1- and TLR4-mediated NF k
appa B activation. MyD88 is a TIR domain-containing adapter molecule known
to have a central role in both IL-1 and TLR4 signaling. A52R mimicked the d
ominant-negative effect of a truncated version of MyD88 on IL-1, TLR4, and
IL-18 signaling but had no effect on MyD88-independent signaling pathways.
Therefore, A46R and A52R are likely to represent a mechanism used by vaccin
ia virus of suppressing TIR domain-dependent intracellular-signaling.